Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The immune microenvironment: a key regulator of ovarian function during ovarian aging.

Frontiers in immunology·2026
Same author

From the Brain Cell Atlas to Precision Neurology: A review of the application of AI-driven multi-omics in brain science.

GigaScience·2026
Same author

Harnessing CRISPR-Cas12 and Microfluidics Chips for Multiplex Respiratory Pathogens Diagnosis.

ACS sensors·2026
Same author

Follicular fluid proteomic alterations associated with oocyte developmental potential in polycystic ovary syndrome.

Frontiers in endocrinology·2026
Same author

Size distribution and diurnal variations of brown carbon absorption using DMF and methanol extraction methods: Implications for the origins of extremely low-volatility organics.

Environmental pollution (Barking, Essex : 1987)·2026
Same author

Capture and Culture of Circulating Tumor Cells Using a Biodegradable 3D Scaffold for Patient-Derived Xenograft Construction.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

A Muscle-Mimetic Core-Sheath Composite Yarn Scaffold for In-Body Tissue Induction and Regeneration of Small-Diameter Vascular Grafts.

Advanced healthcare materials·2026
Same journal

Gardiquimod Nanoemulsion Targets Cutaneous Leishmaniasis Lesions Reducing Systemic Toxicity and Parasite Burden.

Advanced healthcare materials·2026
Same journal

Therapeutic Extracellular Vesicles from Synovial Fibroblast-Primed MSCs for Osteoarthritis Treatment.

Advanced healthcare materials·2026
Same journal

Natural Polysaccharide-Mediated Nano-Delivery Systems for Osteoporosis Therapy From a Gut-Bone Axis Regulatory Perspective.

Advanced healthcare materials·2026
Same journal

A Corrigendum on "Selenium-Albumin Nanoaccelerator Hydrogel Promotes Wound Healing by Antibacterial, Anti-Inflammatory and Antioxidant along with Inhibits Scar Formation via Down-regulating CD36".

Advanced healthcare materials·2026
Same journal

High-Throughput Digital Decoding of Vascular Heterogeneity in Patient-Specific Tumor Microenvironments.

Advanced healthcare materials·2026
See all related articles

Related Experiment Video

Updated: Nov 15, 2025

Bioluminescent Bacterial Imaging In Vivo
05:06

Bioluminescent Bacterial Imaging In Vivo

Published on: November 4, 2012

15.6K

Hypoxic Tumor Radiosensitization Using Engineered Probiotics.

Chunyu Huang1,2, Fu-Bing Wang3, Lei Liu1

  • 1Oncology Department, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.

Advanced Healthcare Materials
|March 1, 2021
PubMed
Summary
This summary is machine-generated.

Engineered bacteria alleviate tumor hypoxia, boosting radiotherapy effectiveness. This probiotic approach enhances oxygen levels and tumor radiosensitivity, inhibiting growth.

Keywords:
catalaseengineered probioticsradiosensitizerstumor hypoxia microenvironmentstumor-targeting

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.6K
Intranasal Delivery of Therapeutic Stem Cells to Glioblastoma in a Mouse Model
09:57

Intranasal Delivery of Therapeutic Stem Cells to Glioblastoma in a Mouse Model

Published on: June 4, 2017

12.5K

Related Experiment Videos

Last Updated: Nov 15, 2025

Bioluminescent Bacterial Imaging In Vivo
05:06

Bioluminescent Bacterial Imaging In Vivo

Published on: November 4, 2012

15.6K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.6K
Intranasal Delivery of Therapeutic Stem Cells to Glioblastoma in a Mouse Model
09:57

Intranasal Delivery of Therapeutic Stem Cells to Glioblastoma in a Mouse Model

Published on: June 4, 2017

12.5K

Area of Science:

  • Biomedical Engineering
  • Microbiology
  • Oncology

Background:

  • Solid tumors require oxygen for effective radiotherapy (RT) due to the need for reactive oxygen species (ROS) generation.
  • Intratumoral hypoxia is a major challenge limiting RT efficacy.
  • Bacteria offer potential as targeted diagnostic or therapeutic bioagents due to their proliferation and genetic manipulability.

Purpose of the Study:

  • To investigate a genetically engineered probiotic bacterium for alleviating intratumoral hypoxia.
  • To enhance tumor radiosensitivity and inhibit tumor growth using engineered bacteria.

Main Methods:

  • Utilized a genetically engineered variant of E. coli Nissle 1917 that secretes catalase.
  • Administered engineered bacteria to alleviate intratumoral hypoxia and enhance radiosensitivity.
  • Assessed O2 evolution, ROS generation, and tumor growth inhibition in vitro and in vivo.

Main Results:

  • Engineered bacteria successfully alleviated intratumoral hypoxia.
  • Robust O2 evolution and ROS generation were observed in response to X-ray irradiation.
  • Significant inhibition of tumor growth was achieved.

Conclusions:

  • Genetically engineered bacteria represent a novel approach to enhance tumor radiosensitivity.
  • This probiotic strategy effectively combats intratumoral hypoxia, improving RT outcomes.
  • Further research in probiotic medicine holds promise for cancer therapy.